logo
  

Baudax Bio Announces Pricing Of $6.2 Mln Public Offering

Baudax Bio Inc. (BXRX) announced the pricing of its public offering of an aggregate of 11.82 million shares of its common stock, together with accompanying common stock purchase warrants, at a public offering price of $0.525 per share and accompanying warrants.

Each share of common stock was sold in the offering together with a Series A-1 warrant to purchase one share of common stock at an exercise price of $0.525 per share and a Series A-2 warrant to purchase one share of common stock at an exercise price of $0.525 per share.

The Series A-1 warrants are exercisable immediately and will expire five years from the date of issuance, and the Series A-2 warrants are exercisable immediately and will expire thirteen months from the date of issuance.

The closing of the offering is expected to occur on or about September 1, 2022.

The company expects the gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, to be about $6.2 million. It plans to use the net proceeds from this offering for pipeline development activities and general corporate purposes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride-hailing and delivery platform Uber Technologies, Inc. reported Wednesday weak profit in its fourth quarter, while adjusted EBITDA surged from last year with strong revenue growth above market view. Gross bookings increased and the company projects higher gross bookings in the first quarter. Nelson Chai, CFO, said the company significantly exceeded profitability outlook in 2022, ... Societe Generale Group reported Wednesday a weak profit in its fourth quarter, despite higher net banking income. Further, the French Financial services major proposed a dividend and around 440 million euros share buyback program. The company also confirmed fiscal 2025 financial targets. City of Industry, California-based Titans Global Inc. is recalling certain JSJ branded cakes citing potential to contain undeclared eggs, a known allergen, the U.S. Food and Drug Administration said. The recall involves its 95g packages of JSJ Chocolate Cake, JSJ ZSR Cake, and JSJ DMC Leaf Cake food treats.
Follow RTT